RANTES is a chemokine produced in delayed-type hypersensitivity (DTH) and allergic reactions, in which it may contribute to the recruitment of immune cells. Macrophages participate in the cellular infiltration in both conditions and they represent a potent source of RANTES. To understand the regulation of RANTES production by human monocytes, we analyzed the effect of cytokines and of corticosteroids on this production. We showed that IFN-y and tumor necrosis factor (TNF)-a cooperated to induce RANTES production by monocytes. Af-acetylcysteine inhibited this effect, indicating that reactive oxygen intermediates are required for RANTES production. Both IL-10 and corticosteroids antagonized the stimulating effect of IFN-7 and TNF-a on RANTES production. In contrast, IL-4 had no effect on IFN-y-induced RANTES production and it potentiated the positive effect of TNF-a on this production. Thus, the deactivating properties of IL-10 and corticosteroids on macrophage functions include RANTES production, and this may contribute to the immunosuppressive effect of both compounds in DTH and allergic reactions. In contrast, IL-4 has an opposite effect on RANTES production and this property may contribute to cell recruitment in allergic reactions. Therefore, although IL-10 and IL-4 belong to the T h 2 family of cytokines, they can display distinct functions in immune reactions.
Introduction
RANTES (1) (regulated on activation normal T expressed and secreted) belongs to the C-C family of chemokines (2,3), and it is a chemoattractant for memory T lymphocytes, monocytes/macrophages, basophils and eosmophils (3-9). We previously showed that RANTES is produced at high levels in granulomatous lesions of delayed-type hypersensitivity (DTH) reactions in humans (10). In these conditions, it mostly originates from endothelial cells and macrophages (10). This has suggested that RANTES is involved in the formation of DTH granulomas, which contain both macrophages and memory CD4 + T h 1 lymphocytes (11,12). This hypothesis was recently supported by our finding that IFN-y and tumor necrosis factor (TNF)-a, two cytokines produced at high levels in DTH granulomas (13-17), act synergistically to induce RANTES production by endothelial cells (18).
according to the micro-environment or to the producing cells The regulation of RANTES production by cells of the monocyte/macrophage lineage has not been reported so far, although this cell population is the main producer of RANTES in DTH granulomas. This study was thus undertaken to address the effect of cytokines and corticosteroids on RANTES production by human monocytes.
Methods

Monocytes populations and culture conditions
Human peripheral blood monocytes were isolated from buffy coats of healthy donors. Mononuclear cells were obtained following two centrifugations on hyperdensity gradients; the first, Lymphoprep, d = 1.077 (Nycomed, Pharma, Oslo, Norway) separating mononuclear cells and platelets from erythrocytes; the second, d = 1.063, separating mononuclear cells from platelets (Nycomed). Mononuclear cells (4x10 6 cells/ml) were then incubated in Petri dishes (Greiner, Laborteknik, Poitiers, France) for 2 h at 37°C in macrophage serum-free medium (macrophage SFM; Gibco/BRL, Cergy-Pontoise, France). After removing nonadherent cells, monocytes were harvested by scraping plates with a rubber policeman in cold PBS solution. More than 95% of cells were of the monocyte cell lineage as assessed by butyrate esterase staining.
In a separate experiment, monocytes were purified by counterflow centrifugal elutnation (26) . The phenotypic analysis of the isolated cells was determined with a FACScan flow cytometer (Becton Dickinson, San Jose, CA) Less than 5% of the cells expressed CD3 or CD20 and 95% of them expressed CD14 These data allowed us to consider this cell preparation as representative of monocytes.
Cells were transferred to sterile polypropylene tubes (Greiner) to avoid adherence of cells during culture; they were incubated for 24 h before stimulation at a concentration of 2x10 6 cells/ml at 37°C in macrophage SFM supplemented with penicillin (10 5 ILJ/ml) and streptomycin (10 5 lU/ml). Stimulation of monocytes was performed in the same tubes with fresh medium. The cytokines IL-4 (PrepoTech, Rocky Hill, NJ) and IL-10 (recombinant IL-10, gift from K Moore, DNAX, Palo Alto, CA) and W-acetylcysteine (NAC) and dexamethasone (DXM) (Sigma, St Louis, MO) were introduced 4 h before adding IFN-y and/or TNF-a (PrepoTech) to the culture. Anti-TNF-a mAb (gift from J. Wijdenes, Diaclone, Besancon, France) was added in some experiments with IFN-y. After adding the stimulating agents, IFN-y and/or TNF-a, the cells were maintained for 48 h in culture. Supernatants were then collected, centrifuged, divided into aliquots and stored frozen at -80°C until use. Viability of cells was assessed using Trypan blue exclusion. Also, we checked that the concentrations of NAC and DXM used were not toxic
Detection of RANTES production
Concentrations of RANTES were measured using a RANTES sandwich ELISA assay purchased from Amersham (Les Ulis, France). This test employs two antibodies specific for Fig. 1 . Effect of IFN-y and TNF-a on RANTES production by monocytes. Monocytes were cultured for 48 h with or without IFN-y (500 U/ml) and with or without TNF-a (250 U/ml) RANTES concentration was then determined in the supernatant Results are expressed as the mean (± SEM) RANTES production obtained from 21 experiments RANTES: the first used for coating is an anti-RANTES mAb and the second is an enzyme-linked polyclonal antibody The sensitivity of the test was 2.5 pg/ml.
Statistical analysis
Statistical analysis was performed using a Wilcoxon test with P < 0.05 considered as significant.
Results
IFN-y and TNF-a induction of RANTES production by human monocytes
We analyzed the effect of IFN-y and TNF-a on RANTES production by monocytes. Cells were cultured with or without cytokines and RANTES concentration was determined in the supernatants after 48 h of culture. In the absence of cytokine, we detected variable RANTES production (from 24 to 515 pg/ml). The addition of either IFN-y or TNF-a significantly stimulated RANTES production (P = 0 002 and P = 0.004 respectively). The RANTES production obtained in the presence of both IFN-y and TNF-a was significantly higher than that obtained in the presence of IFN-y alone (P = 0.009) or TNF-a alone (P < 0 0001) (Fig. 1) We performed in situ hybridization experiments (27) with a RANTES probe on unstimulated monocytes and on monocytes cultured for 24 h in the presence of IFN-y and TNFa. The fraction of cells hybridizing the RANTES probe was <10% in the former and >80% in stimulated cells (data not shown). This is in agreement with our previous finding on alveolar macrophages (10). This shows that RANTES production in our culture conditions does not arise from contaminating cells.
We then determined whether the dose-effect curve of IFN-y on RANTES production differed according to the presence of TNF-a in culture. Regardless of the presence of TNF-a, an optimal effect was obtained only for the highest concentration of IFN-y (500 U/ml) (Fig. 2) . 
Role of endogenous TNF-a in RANTES production by monocytes
To determine whether a variability of endogenous production of TNF-a accounted for the variable spontaneous production of RANTES, we tested the effect of an anti-TNF-a mAb on RANTES production by unstimulated monocytes. This mAb inconsistently decreased the spontaneous production of RANTES (Fig. 3a) . As IFN-y stimulates TNF-a production by monocytes (28,29 and data not shown), we investigated whether this mechanism is involved in the IFN-y enhancement of RANTES production. Addition of a neutralizing anti-TNFa mAb to the cultures completely abrogated the stimulating effect of IFN-y on RANTES production (Fig. 3b) .
Inhibition of RANTES production by NAC
The previous results showed that IFN-y and TNF-a act synergistically to up-regulate RANTES production by monocytes. We asked whether production of reactive oxygen intermediates (ROI) are involved in such a synergy. NAC was added to monocytes either unstimulated or stimulated with IFN-y and TNF-a. RANTES concentration was measured in the supernatant 48 h later. NAC alone did not affect the spontaneous production of RANTES. In contrast, it significantly inhibited the production obtained in the presence of IFN-y alone (P = 0.002), of TNF-a alone (P = 0.01) and with a combination of IFN-y and TNF-a (P = 0.002) (Fig. 4) .
Regulation of RANTES production by DXM and IL-10
Graded concentrations of DXM were added to monocytes cultured either alone or in the presence of IFN-y and TNF-a. DXM strongly inhibited the production of RANTES by both stimulated and unstimulated monocytes This inhibition was dose related and optimal for the 10~7 M concentration of DXM (Fig. 5) We then investigated whether the T h 2-type cytokine IL-10 modulates RANTES production. IL-10 did not affect the spontaneous release of RANTES by monocytes. In contrast, IL-10 significantly decreased the production of RANTES induced by IFN-y alone (P = 0.001), TNF-a alone (P = 0.017) or a combination of IFN-y and TNF-a 1000 ' Fig. 6 . Effect of IL-10 on RANTES production by monocytes. Monocytes were cultured alone or in the presence of IFN-y (500 U/ml), TNF-a (250 U/ml), and/or IL10 (20 ng/ml). Results are expressed as the mean (± SEM) RANTES production obtained from 14 experiments.
(P = 0 001) (Fig. 6 ) The inhibiting effect of IL-10 on IFNy-induced RANTES production was observed even in the presence of exogenous TNF-a, reflecting a direct effect on RANTES production and not an indirect effect through an inhibition of TNF-a synthesis.
Effect of IL-4 on RANTES production
We then asked whether the effect on RANTES production of IL-4, another T h 2-type cytokine, differed from that of IL-10. IL-4 did not affect the spontaneous production of RANTES by monocytes. It also had no effect on the production of RANTES induced by IFN-y alone or by the association of IFNy and TNF-a. When TNF-a was used as a single stimulant, production of RANTES was increased by IL-4 (P = 0.001) (Fig. 7a) . We performed a similar experience on monocytes purified by elutriation. In this case, there was no production of RANTES by unstimulated cells or by cells cultured in the presence of IL-4 alone. In the other stimulating conditions, the results obtained with elutriated cells were similar to those obtained with monocytes purified by adherence. Particularly, IL-4 potentiated RANTES production in the presence of TNFa (Fig. 7b) . Therefore, the effect of IL-4 on RANTES production was clearly different from that of IL-10.
Discussion
We previously showed that macrophages represent a potent source of RANTES, either in vivo in DTH granuiomas or in vitro (10). Here, we addressed the role of T h 1 and T h 2-type cytokines and of corticosteroids in RANTES production by monocytes.
We first focused our studies on IFN-y and TNF-a, two cytokines produced at high levels in DTH granuiomas (13-17). We showed that each cytokine alone was able to stimulate RANTES production by monocytes, but that the combination of both cytokines was more efficient than either cytokine used alone. This RANTES production was not due to contaminating cells such as dendritic cells, as it was also observed by monocytes highly purified by elutriation, and because the Such a synergistic effect of IFN-y and TNF-a on RANTES production has already been reported for endothelial cells (18) . In this latter model, exogenous TNF-a is absolutely required for RANTES production. This contrasts with monocytes, for which IFN-y alone was sufficient to stimulate RANTES production. Whereas endothelial cells are unable to produce TNF-a, monocytes produce large amounts of this cytokine, particularly following IFN-y stimulation (28, 29) . We showed that this endogenous production of TNF-a by monocytes was absolutely required for the effect of IFN-y on RANTES production. Indeed, addition of an anti-TNF-a mAb to IFN-ystimulated monocytes abrogated the induction of RANTES production.
The role of IFN-y in RANTES production by monocytes was not restricted to an induction of endogenous TNF-a synthesis. It also cooperated with the stimulating signal induced by TNF-a; the production of RANTES was consistently higher when IFN-y and TNF-a were simultaneously added than when TNF-a was present alone. Although we cannot exclude additional mechanisms of action of IFN-y, we showed that part of its effect on RANTES production by monocytes was mediated through ROI. IFN-y strongly stimulates ROI generation by macrophages (30) We showed that addition of NAC, a ROI scavenger, completely abrogated the stimulating effect of IFN-y on RANTES production. ROI have been shown to potentiate the activating signal transmitted through the TNF receptor. This cooperation may involve NF-KB, which plays a critical role in the pathway of cell activation by TNF receptors (31, 32) . Moreover, NF-KB activation is optimal in the presence of ROI (33) (34) (35) (36) and is inhibited by NAC (37) As the regulatory region of the RANTES gene contains a DNA-binding site for NF-KB (38) , the positive role of TNF-a and IFN-y on RANTES production may be to synergistically activate NF-KB in monocytes, thus allowing RANTES gene transcription. Such a mechanism of cooperation between IFN-y and TNF-a through a concerted regulation of NF-KB activity has already been reported to explain their effect on the regulation of two other chemokines, IL-8 (39) and IP-10 (40).
Corticosteroids are potent inhibitors of DTH granuloma formation (22) They may act at least in part by affecting the production of chemokines (41), among which is RANTES. The effect of corticosteroids on RANTES production may itself be dual. As corticosteroids inhibit IFN-y production by T lymphocytes (42) and TNF-a production by macrophages (43) (44) (45) , this may indirectly down-regulate RANTES production. In addition, we showed that corticosteroids strongly antagonized the effect of IFN-y and TNF-a on RANTES production. This observation is consistent with the ability of corticosteroids to inhibit TNF receptor-mediated signals and NF-KB activation (46, 47) , and to decrease ROI formation by macrophages (48) We showed that IL-10 inhibited the monocyte synthesis of RANTES induced by IFN-y and/or TNF-a. This indicates that the ability of IL-10 to inhibit DTH granuloma formation may be at least partially mediated by an inhibition of RANTES production by granulomatous macrophages, resulting in an impairment of cell recruitment Moreover, macrophages can produce large amounts of IL-10 upon TNF-a stimulation. This endogenous production of IL-10 may participate in the regulation of RANTES production (50) . The sensitivity to IL-10 inhibition of RANTES production by monocytes contrasts with the insensitivity observed with endotheiial cells (18). Similar findings were already reported for IL-6 production, which is inhibited by IL-10 in monocytes but not in endotheiial cells (49) Inhibition of the monocyte-derived production of cytokines, including RANTES, by IL-10 is an important aspect of the deactivating property of IL-10 on macrophage functions (50) (51) (52) (53) (54) (55) (56) .
In contrast to IL-10, IL-4 did not inhibit RANTES production by monocytes. IL-4 potentiated the stimulating effect of TNF-a on RANTES production by these cells. Whereas IL-4 inhibits a number of macrophage functions (57) (58) (59) (60) (61) , it stimulates their expression of MHC class II molecules (62, 63) , their ability of antigen presentation (64, 65) , their production of IL-1 receptor agonist (66) and their maturation (67) . Production of RANTES thus belongs to this second group of macrophage functions, being positively modulated by IL-4.
Mast cells play a critical role in initiating allergic reactions through triggering of the Fc receptor by IgE and antigen. It is interesting to point out that this activation leads to a release of both TNF-a and IL-4 by mast cells (23, 68, 69) . In view of our results, this would stimulate RANTES production by resident macrophages, recruiting inflammatory cells and eosinophils. In a following step, additional TNF-a and IL-4 would originate from macrophages (70), T lymphocytes and eosinophils (71) (72) (73) , thus perpetuating the cell influx initiated by mast cells (74) .
An interesting aspect of our study is the dissociated effect on RANTES production of IL-4 in contrast to IL-10 and corticosteroids. As already mentioned, corticosteroids and IL-10 inhibit NF-KB activation and ROI formation in monocytes/ macrophages, and this may explain their inhibition of RANTES production This latter effect presumably contributes to the down-modulation of both DTH and allergic reactions by corticosteroids and IL-10 (75,76). However, IL-4 does not affect NF-KB activity in monocytes (77) , which may explain its different effect on RANTES production as compared to IL-10 and corticosteroids. This may also explain how IL-4 is not a 'general deactivated' of cellular immunity and of cell recruitment as are IL-10 and corticosteroids, but rather an agent influencing the characteristics of an ongoing immune response.
Therefore, TNF-a in association with either IFN-y or IL-4 stimulates the production of RANTES by monocytes. This presumably explains how RANTES is produced at high levels in either DTH granulomas or allergic reactions. In conjunction with other chemokines (23, (78) (79) (80) , RANTES may thus contribute to cell recruitment in both disorders. The limitation of DTH reactions and allergic reactions by corticosteroids and by IL-10 may involve a down-modulation of RANTES production by macrophages accumulating in the pathological infiltrate. In contrast, the induction of monocyte-derived RANTES production by IL-4 and TNF-a may be a critical step in the constitution and enrichment of cellular infiltrates in allergic reactions. IL-10 and IL-4 belong to the T h 2 cytokine family, and they share some common functions This is not the case for RANTES production by monocytes, for which they have opposite effects. Their function is thus not redundant and each cytokine plays a specific role in immune reactions. 
